Search Results | American Association for Cancer Research

1-20 of 33979

2 3 4 5

Sort by

Sort Order Select

Journal Articles

Mechanism of dichotomy between CD8+ responses elicited by apoptotic and necrotic cells

Matthew R. Buckwalter, Pramod K. Srivastava

Cancer Immun (2013) 13 (1): 2.

DOI: https://doi.org/10.1158/1424-9634.DCL-2.13.1

Published: 01 January 2013

View article

Journal Articles

A novel human-derived antibody against NY-ESO-1 improves the efficacy of chemotherapy

Anurag Gupta, Natko Nuber, Christoph Esslinger, Mareike Wittenbrink, Martin Treder, Alexandro Landshammer, Takuro Noguchi, Marcus Kelly, Sacha Gnjatic, Erika Ritter, Lotta von Boehmer, Hiroyoshi Nishikawa, Hiroshi Shiku, Lloyd Old, Gerd Ritter, Alexander Knuth, Maries van den Broek

Cancer Immun (2013) 13 (1): 3.

DOI: https://doi.org/10.1158/1424-9634.DCL-3.13.1

Published: 01 January 2013

View article

Journal Articles

Intraepithelial T cells and tumor-associated macrophages in ovarian cancer patients

Paulette Mhawech-Fauceglia, Dan Wang, Liaquat Ali, Shashikant Lele, Michael A. Huba, Song Liu, Kunle Odunsi

Cancer Immun (2013) 13 (1): 1.

DOI: https://doi.org/10.1158/1424-9634.DCL-1.13.1

Published: 01 January 2013

View article

Journal Articles

An analogue peptide from the Cancer/Testis antigen PASD1 induces CD8+ T cell responses against naturally processed peptide

Nicola Hardwick, Sarah Buchan, Wendy Ingram, Ghazala Khan, Gisella Vittes, Jason Rice, Karen Pulford, Ghulam Mufti, Freda Stevenson, Barbara-ann Guinn

Cancer Immun (2013) 13 (3): 16.

DOI: https://doi.org/10.1158/1424-9634.DCL-16.13.3

Published: 01 January 2013

View article

Journal Articles

BORIS/CTCFL mRNA isoform expression and epigenetic regulation in epithelial ovarian cancer

Petra A. Link, Wa Zhang, Kunle Odunsi, Adam R. Karpf

Cancer Immun (2013) 13 (1): 6.

DOI: https://doi.org/10.1158/1424-9634.DCL-6.13.1

Published: 01 January 2013

View article

Journal Articles

Expression of CD1c enhances human invariant NKT cell activation by α-GalCer

Lisa M. Fox, Jennifer Miksanek, Nathan A. May, Louise Scharf, Jennifer L. Lockridge, Natacha Veerapen, Gurdyal S. Besra, Erin J. Adams, Amy W. Hudson, Jenny E. Gumperz

Cancer Immun (2013) 13 (2): 9.

DOI: https://doi.org/10.1158/1424-9634.DCL-9.13.2

Published: 01 January 2013

View article

Journal Articles

NY-ESO-1–specific immunological pressure and escape in a patient with metastatic melanoma

Lotta von Boehmer, Muriel Mattle, Peter Bode, Alexandro Landshammer, Carolin Schäfer, Natko Nuber, Gerd Ritter, Lloyd Old, Holger Moch, Niklaus Schäfer, Elke Jäger, Alexander Knuth, Maries van den Broek

Cancer Immun (2013) 13 (3): 12.

DOI: https://doi.org/10.1158/1424-9634.DCL-12.13.3

Published: 01 January 2013

View article

Journal Articles

Hsp72 mediates stronger antigen-dependent non-classical MHC class Ib anti-tumor responses than hsc73 in Xenopus laevis

Hristina Nedelkovska, Jacques Robert

Cancer Immun (2013) 13 (1): 4.

DOI: https://doi.org/10.1158/1424-9634.DCL-4.13.1

Published: 01 January 2013

View article

Journal Articles

Randomized phase I pharmacokinetic study of ipilimumab with or without one of two different chemotherapy regimens in patients with untreated advanced melanoma

Jeffrey Weber, Omid Hamid, Asim Amin, Steven O’Day, Eric Masson, Stacie M. Goldberg, Daphne Williams, Susan M. Parker, Scott D. Chasalow, Suresh Alaparthy, Jedd D. Wolchok

Cancer Immun (2013) 13 (2): 7.

DOI: https://doi.org/10.1158/1424-9634.DCL-7.13.2

Published: 01 January 2013

View article

Journal Articles

Human ovarian tumor ascites fluids rapidly and reversibly inhibit T cell receptor-induced NF-κB and NFAT signaling in tumor-associated T cells

Michelle R. Simpson-Abelson, Jenni L. Loyall, Heather K. Lehman, Jennifer L. Barnas, Hans Minderman, Kieran L. O’Loughlin, Paul K. Wallace, Thaddeus C. George, Peng Peng, Raymond J. Kelleher, Jr., Kunle Odunsi, Richard B. Bankert

Cancer Immun (2013) 13 (3): 14.

DOI: https://doi.org/10.1158/1424-9634.DCL-14.13.3

Published: 01 January 2013

View article

Journal Articles

Changes in ovarian tumor cell number, tumor vasculature, and T cell function monitored in vivo using a novel xenograft model

Sandra J. Yokota, John G. Facciponte, Raymond J. Kelleher, Jr., Leonard D. Shultz, Jenni L. Loyall, Robert R. Parsons, Kunle Odunsi, John G. Frelinger, Edith M. Lord, Scott A. Gerber, Sathy V. Balu-Iyer, Richard B. Bankert

Cancer Immun (2013) 13 (2): 11.

DOI: https://doi.org/10.1158/1424-9634.DCL-11.13.2

Published: 01 January 2013

View article

Journal Articles

Chromosome X-encoded Cancer/Testis antigens are less frequently expressed in non-seminomatous germ cell tumors than in seminomas

Yao-Tseng Chen, Dengfeng Cao, Rita Chiu, Peishan Lee

Cancer Immun (2013) 13 (2): 10.

DOI: https://doi.org/10.1158/1424-9634.DCL-10.13.2

Published: 01 January 2013

View article

Journal Articles

Evaluation of LAGE-1 and NY-ESO-1 expression in multiple myeloma patients to explore possible benefits of their homology for immunotherapy

Fabricio de Carvalho, Andre L. Vettore, Riguel J. Inaoka, Bruno Karia, Valéria C. C. Andrade, Sacha Gnjatic, Achim A. Jungbluth, Gisele W. B. Colleoni

Cancer Immun (2011) 11 (1): 1.

DOI: https://doi.org/10.1158/1424-9634.DCL-1.11.1

Published: 01 January 2011

View article

Journal Articles

Progression of cancer from indolent to aggressive despite antigen retention and increased expression of interferon-gamma inducible genes

Terry H. Wu, Karin Schreiber, Ainhoa Arina, Nikolai N. Khodarev, Elena V. Efimova, Donald A. Rowley, Ralph R. Weichselbaum, Hans Schreiber

Cancer Immun (2011) 11 (1): 2.

DOI: https://doi.org/10.1158/1424-9634.DCL-2.11.1

Published: 01 January 2011

View article

Journal Articles

Ipilimumab efficacy and safety in patients with advanced melanoma: a retrospective analysis of HLA subtype from four trials

Jedd D. Wolchok, Jeffrey S. Weber, Omid Hamid, Celeste Lebbé, Michele Maio, Dirk Schadendorf, Veerle de Pril, Kevin Heller, Tai-Tsang Chen, Ramy Ibrahim, Axel Hoos, Steven J. O'Day

Cancer Immun (2010) 10 (1): 9.

DOI: https://doi.org/10.1158/1424-9634.DCL-9.10.1

Published: 01 January 2010

View article

Journal Articles

Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapy

Jianda Yuan, David B. Page, Geoffrey Y. Ku, Yanyun Li, Zhenyu Mu, Charlotte Ariyan, Humilidad F. Gallardo, Ruth-Ann Roman, Agnes I. Heine, Stephanie L. Terzulli, Erika Ritter, Sacha Gnjatic, Gerd Ritter, Achim A. Jungbluth, James P. Allison, Lloyd J. Old, Jedd D. Wolchok

Cancer Immun (2010) 10 (1): 1.

DOI: https://doi.org/10.1158/1424-9634.DCL-1.10.1

Published: 01 January 2010

View article

Journal Articles

Possible significance of differences in proportions of cytotoxic T cells and B-lineage cells in the tumour-infiltrating lymphocytes of typical and atypical medullary carcinomas of the breast

Kok Haw Jonathan Lim, Premasiri Upali Telisinghe, Muhd Syafiq Abdullah, Ranjan Ramasamy

Cancer Immun (2010) 10 (1): 3.

DOI: https://doi.org/10.1158/1424-9634.DCL-3.10.1

Published: 01 January 2010

View article

Journal Articles

High efficiency CD91- and LOX-1-mediated re-presentation of gp96-chaperoned peptides by MHC II molecules

Toyoshi Matsutake, Tatsuya Sawamura, Pramod K. Srivastava

Cancer Immun (2010) 10 (1): 7.

DOI: https://doi.org/10.1158/1424-9634.DCL-7.10.1

Published: 01 January 2010

View article

Journal Articles

Cellular immune responses against CT7 (MAGE-C1) and humoral responses against other cancer-testis antigens in multiple myeloma patients

Nikoletta Lendvai, Sacha Gnjatic, Erika Ritter, Michael Mangone, Wayne Austin, Karina Reyner, David Jayabalan, Ruben Niesvizky, Sundar Jagannath, Nina Bhardwaj, Selina Chen-Kiang, Lloyd J. Old, Hearn Jay Cho

Cancer Immun (2010) 10 (1): 4.

DOI: https://doi.org/10.1158/1424-9634.DCL-4.10.1

Published: 01 January 2010

View article

Journal Articles

BORIS/CTCFL expression is insufficient for cancer-germline antigen gene expression and DNA hypomethylation in ovarian cell lines

Anna Woloszynska-Read, Smitha R. James, Chajoun Song, Boquan Jin, Kunle Odunsi, Adam R. Karpf

Cancer Immun (2010) 10 (1): 6.

DOI: https://doi.org/10.1158/1424-9634.DCL-6.10.1

Published: 01 January 2010

View article

2 3 4 5

NARROW

Mechanism of dichotomy between CD8+ responses elicited by apoptotic and necrotic cells

A novel human-derived antibody against NY-ESO-1 improves the efficacy of chemotherapy

Intraepithelial T cells and tumor-associated macrophages in ovarian cancer patients

An analogue peptide from the Cancer/Testis antigen PASD1 induces CD8+ T cell responses against naturally processed peptide

BORIS/CTCFL mRNA isoform expression and epigenetic regulation in epithelial ovarian cancer

Expression of CD1c enhances human invariant NKT cell activation by α-GalCer

NY-ESO-1–specific immunological pressure and escape in a patient with metastatic melanoma

Hsp72 mediates stronger antigen-dependent non-classical MHC class Ib anti-tumor responses than hsc73 in Xenopus laevis

Randomized phase I pharmacokinetic study of ipilimumab with or without one of two different chemotherapy regimens in patients with untreated advanced melanoma

Human ovarian tumor ascites fluids rapidly and reversibly inhibit T cell receptor-induced NF-κB and NFAT signaling in tumor-associated T cells

Changes in ovarian tumor cell number, tumor vasculature, and T cell function monitored in vivo using a novel xenograft model

Chromosome X-encoded Cancer/Testis antigens are less frequently expressed in non-seminomatous germ cell tumors than in seminomas

Evaluation of LAGE-1 and NY-ESO-1 expression in multiple myeloma patients to explore possible benefits of their homology for immunotherapy

Progression of cancer from indolent to aggressive despite antigen retention and increased expression of interferon-gamma inducible genes

Ipilimumab efficacy and safety in patients with advanced melanoma: a retrospective analysis of HLA subtype from four trials

Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapy

Possible significance of differences in proportions of cytotoxic T cells and B-lineage cells in the tumour-infiltrating lymphocytes of typical and atypical medullary carcinomas of the breast

High efficiency CD91- and LOX-1-mediated re-presentation of gp96-chaperoned peptides by MHC II molecules

Cellular immune responses against CT7 (MAGE-C1) and humoral responses against other cancer-testis antigens in multiple myeloma patients

BORIS/CTCFL expression is insufficient for cancer-germline antigen gene expression and DNA hypomethylation in ovarian cell lines

AACR Journals

AACR Journals

This Feature Is Available To Subscribers Only